Sight Sciences, Inc.
NASDAQSight Sciences reports Q1 2026 earnings today with the stock up 22% over the past month — but analysts still deeply divided on whether that rally reflects genuine fundamental recovery or gets ahead of the evidence. The price rebound tells a striking story. After a brutal March 4 print that sent the stock down nearly 25% in a single session and almost 30% over the following five…
Snapshot as of 7 May 2026
Sight Sciences reports Q1 2026 earnings today with the stock up 22% over the past month — but analysts still deeply divided on whether that rally reflects genuine fundamental recovery or gets ahead of the evidence. The…
Sight Sciences just delivered a split verdict — Q1 sales beat but earnings missed, and then management raised the full-year bar anyway. That combination is the heart of this week's setup heading into the post-earnings…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SGHT — free to start on ORTEX.
Sign up for free →Open SGHT on ORTEX